First Shanghai Investments Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

1.67

EPS

—

Div Yield, %

—

Shrs. gr., 5y

2.72%

Rev. gr., 5y

-7.96%

Revenues

362m

+15.74%

Net income

78m

CFO

-100.00%

Dividend

Jun 08, 20160.01 HKD/sh

Earnings

May 23, 2025

Profile

First Shanghai Investments Limited, an investment holding company, engages in financial services, property and hotel, medical and healthcare, and direct investment sectors in Hong Kong, the People's Republic of China, and internationally. The company offers securities investment, securities broking, margin financing, corporate finance, underwriting and placements, asset management, wealth management, shares placement, IPO subscription, shares custodian, nominee, financial intermediary, and investment advisory services. It also develops residential, service apartment, commercial office, industrial office, hotel, and recreation resort properties; develops and commercializes therapeutic drugs; and provides container transportation and freight forwarding services. In addition, the company operates a medical center in Central, Hong Kong that provides medical and healthcare services, including imaging, day surgery, endoscopy, and check-up services, as well as medical beauty treatments, and general and specialist consultation services. Further, it provides money lending, nominee, agency, management and secretarial, financial leasing and consultancy, internet financial service system, dental, futures broking, stock broking, insurance broking, and property investment services, as well as operates hotel and golf course. The company was formerly known as Public International Investments Limited and changed its name to First Shanghai Investments Limited in June 1993. First Shanghai Investments Limited was founded in 1964 and is based in Central, Hong Kong.

URL

https://www.firstshanghai.com.hk/zh-hant/

IPO date

Aug 24, 1972

Employees

566

Domiciled in

Incorporated in

Valuation

Order:

Title HKD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title HKD in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	362,128 15.74%	312,875 -8.57%	342,183 -35.42%
Cost of revenue		374,621	408,255
Unusual Expense (Income)
NOPBT	362,128	(61,746)	(66,072)
NOPBT Margin	100.00%
Operating Taxes	8,016	15,837	(4,969)
Tax Rate	2.21%
NOPAT	354,112	(77,583)	(61,103)
Net income	77,974 -833.60%	(10,629) -81.94%	(58,844) -60.51%
Dividends
Dividend yield
Proceeds from repurchase of equity		66,246	1,863
BB yield		-35.05%	-0.67%
Debt
Debt current		148,934	166,866
Long-term debt	30,009	94,573	125,195
Deferred revenue			53,180
Other long-term liabilities	2,293,533	876	(52,923)
Net debt	(254,641)	(119,375)	19,460
Cash flow
Cash from operating activities		6,012	(66,510)
CAPEX		(2,834)	(9,369)
Cash from investing activities		114,893	86,713
Cash from financing activities		(24,942)	(92,353)
FCF	(1,984,454)	(831,851)	(4,354,039)
Balance
Cash	284,650	334,668	241,856
Long term investments		28,214	30,745
Excess cash	266,544	347,238	255,492
Stockholders' equity	2,556,028	2,470,307	2,380,013
Invested Capital	4,613,026	2,299,066	2,344,505
ROIC	10.25%
ROCE	7.42%
EV
Common stock shares outstanding	2,190,680	1,643,653	1,564,546
Price	0.24 109.57%	0.12 -35.75%	0.18 -12.68%
Market cap	527,954 179.31%	189,020 -32.51%	280,054 -6.19%
EV	341,456	173,795	362,739
EBITDA	362,128	(19,782)	(21,391)
EV/EBITDA	0.94
Interest		36,472	15,289
Interest/NOPBT